Morphine Milligram Equivalent (MME): What PI Attorneys Need to Know

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Morphine milligram equivalent (MME) is the standardized metric for comparing opioid doses across different medications. PI attorneys need to understand MME because defense counsel uses it to argue excessive prescribing. Learn how to interpret MME data and present it as evidence of legitimate pain severity.

Morphine milligram equivalent (MME) is the standardized clinical metric used to compare the potency of different opioid medications on a single scale. In personal injury litigation, MME data is increasingly relevant because defense counsel cites MME thresholds to argue that a plaintiff's opioid regimen is excessive -- and plaintiff attorneys must understand MME well enough to counter those arguments with clinical context that demonstrates the prescription reflects legitimate, medically necessary pain management.

• MME converts different opioid medications to a common potency scale, allowing comparison across drug types and dosages
• The CDC's 2022 guideline recommends caution above 50 MME/day and careful reassessment above 90 MME/day -- but these are clinical guidance, not prescriptive limits
• LienScripts tracks MME calculations for every case involving opioid therapy, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that contextualizes opioid dosing within the treatment narrative
• Defense counsel increasingly cites MME thresholds to argue excessive prescribing; plaintiff attorneys need to understand why a high MME may be clinically appropriate
• A plaintiff on a high MME regimen is, by definition, managing severe pain that lower doses and non-opioid alternatives could not control

What MME Is and How It Works

Different opioid medications have different potencies. A 10mg dose of oxycodone is not equivalent to a 10mg dose of morphine or a 10mg dose of hydrocodone. To compare them, clinicians convert each opioid dose to its morphine milligram equivalent using published conversion factors.

For example:

• Hydrocodone 10mg = 10 MME (conversion factor: 1)
• Oxycodone 10mg = 15 MME (conversion factor: 1.5)
• Tramadol 50mg = 5 MME (conversion factor: 0.1)

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "MME is a clinical tool designed to help prescribers and pharmacists assess cumulative opioid exposure. It was never intended as a litigation weapon. When I see a plaintiff at 60 or 80 MME/day after a multi-level spinal injury, that dose tells me the injury is severe and other treatments have been inadequate. Defense attorneys who cite MME numbers without clinical context are misusing a clinical tool."

A plaintiff's total daily MME is calculated by converting all concurrently prescribed opioids to their morphine equivalents and summing them. A patient taking hydrocodone 10mg four times daily (40 MME) plus oxycodone 5mg twice daily for breakthrough pain (15 MME) has a total daily MME of 55.

Why Defense Uses MME Against Plaintiffs

Since the opioid crisis became a public health focus, defense counsel has seized on MME thresholds as ammunition. The typical defense argument follows this structure:

1. The CDC recommends caution above 50 MME/day
2. The plaintiff is prescribed 60+ MME/day
3. Therefore, the plaintiff is being overprescribed
4. Therefore, the treatment is excessive and damages should be reduced

This argument misrepresents the CDC guideline, which explicitly states that dosing decisions should be individualized based on patient needs and that the recommended thresholds are not rigid limits. The guideline applies to primary care settings and chronic pain management, not to acute traumatic injury management.

How to Counter the MME Defense

Clinical Context Is Everything

A plaintiff at 70 MME/day after a multi-car collision with three herniated discs, a fractured rib, and a torn rotator cuff is not being overprescribed. The dose reflects the severity of the injuries. The relevant question is not whether the dose exceeds an arbitrary threshold, but whether the dose is clinically appropriate for the documented injuries -- and the treating physician has already answered that question by prescribing the regimen.

The Treatment Escalation Narrative

High MME typically represents the end point of a treatment escalation pathway. The plaintiff likely started on low-dose, short-acting opioids, progressed through dose increases as pain persisted, and may have tried and failed on non-opioid alternatives. The pharmacy record showing this progression demonstrates that the current dose was reached through systematic clinical decision-making, not reckless prescribing.

Prescriber Justification

Every opioid prescription above standard thresholds requires the prescriber to document clinical justification. When a physician continues to prescribe at a given MME level, they are repeatedly certifying that the dose is medically necessary for the patient's condition. This ongoing prescriber judgment is clinical evidence of pain severity.

MME as Evidence of Injury Severity

Rather than allowing defense to weaponize MME, plaintiff attorneys should reframe high MME as evidence of injury severity:

• High MME = severe pain. A plaintiff who requires 60+ MME/day has pain that lower doses, non-opioid medications, and non-pharmacological interventions could not adequately manage. The dose itself documents severity.
• Stable MME = ongoing need. A plaintiff whose daily MME has remained stable for months is not escalating dose (which might suggest tolerance or misuse) -- they are on a maintenance regimen that their prescriber has determined is necessary.
• Decreasing MME = appropriate tapering. A plaintiff whose MME has decreased over time is demonstrating appropriate pain management under medical supervision, countering any narrative of dependence.

Presenting MME Evidence in Demand Packages

Include MME analysis in every demand package involving opioid therapy:

1. MME timeline -- chart showing daily MME over the treatment period
2. Clinical context -- the injuries and conditions that necessitate opioid therapy at the documented level
3. Treatment alternatives tried -- non-opioid medications and interventions attempted before or alongside opioid therapy
4. Prescriber monitoring -- documentation of regular follow-up visits, urine drug screens, and PDMP checks
5. Guideline compliance -- noting that the prescriber follows appropriate monitoring protocols regardless of MME level

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes MME calculations with clinical context explaining the dosing rationale.

Practical Takeaways

MME is a clinical measurement tool, not a litigation standard. Plaintiff attorneys who understand MME can transform a potential defense weapon into affirmative evidence of injury severity. A high MME dose, supported by clinical context and documented treatment escalation, tells the story of a plaintiff whose pain is severe enough to require aggressive pharmacological management -- because of the defendant's negligence.

Related Resources

• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary
• DEA Scheduling as Pain Severity Indicator -- Using controlled substance schedules as severity evidence
• Dose Escalation Documents Injury Progression -- How dosage increases prove worsening condition